CIMT & Carotid Duplex Ultrasound
A detailed guide to carotid intima-media thickness, carotid plaque, blood-flow assessment and how carotid ultrasound may contribute to a broader cardiovascular risk assessment.
Contents
What is a CIMT and carotid duplex ultrasound?
A carotid ultrasound is a non-invasive examination of the arteries on either side of the neck. It can assess arterial wall structure, detect atherosclerotic plaque and evaluate blood flow through the carotid arteries using Doppler ultrasound.
CIMT
Carotid intima-media thickness measures the combined thickness of the inner arterial wall layers, usually within a standardised segment of the common carotid artery.
Plaque assessment
Ultrasound can identify focal atherosclerotic plaque, describe its location and morphology and assess whether plaque narrows the arterial lumen.
Duplex Doppler
Doppler measures blood-flow velocities and waveform characteristics to determine whether narrowing has a significant effect on flow.
Why the carotid arteries matter
The carotid circulation
There is a common carotid artery on each side of the neck. Each usually divides at the carotid bifurcation into the internal carotid artery, which supplies the brain and eyes, and the external carotid artery, which supplies structures of the face and neck.
The carotid bulb and proximal internal carotid artery are common sites for atherosclerotic plaque. These locations are accessible to high-resolution B-mode and Doppler ultrasound.
Because atherosclerosis is a systemic process, visible carotid plaque may provide information about the presence of atherosclerotic disease beyond the neck. However, carotid ultrasound does not directly image the coronary arteries.
What is CIMT?
CIMT is the combined thickness of the intima and media — two layers of the arterial wall that can be visualised as parallel interfaces on high-resolution B-mode ultrasound.
How CIMT is measured
CIMT is generally measured in a standardised plaque-free segment of the common carotid artery, commonly using the far wall where the lumen-intima and media-adventitia interfaces can be visualised.
Standardisation matters. The measured value can be affected by the precise segment chosen, image quality, equipment, measurement technique and whether focal plaque has been inadvertently included.
What influences CIMT?
- Age and vascular ageing
- Blood pressure
- Smoking exposure
- Cholesterol and other metabolic risk factors
- Diabetes and insulin resistance
- Measurement methodology
CIMT is not the same as carotid plaque
This is one of the most important concepts in carotid cardiovascular assessment. Increased CIMT is a diffuse arterial-wall measurement. Carotid plaque is a focal structural lesion.
Measures the intima-media complex in a defined arterial segment.
Represents a focal structural abnormality consistent with atherosclerotic change.
Describes narrowing of the arterial lumen and is graded using structural and Doppler information.
How is plaque defined?
The Mannheim consensus describes plaque as a focal structure that encroaches into the arterial lumen by at least 0.5 mm, or by at least 50% compared with the surrounding intima-media thickness, or has a thickness greater than 1.5 mm measured from the media-adventitia interface to the intima-lumen interface.
A person may therefore have a relatively modest CIMT measurement but still have focal plaque at the carotid bulb or proximal internal carotid artery. Conversely, a thicker arterial wall does not automatically mean that a focal plaque is present.
What does a carotid duplex scan assess?
Structural assessment
- Common carotid artery
- Carotid bulb and bifurcation
- Internal carotid artery
- External carotid artery where appropriate
- Vertebral arteries where included in the protocol
- Plaque location, size and morphology
- Calcification and acoustic shadowing
Haemodynamic assessment
- Peak systolic velocity (PSV)
- End-diastolic velocity (EDV)
- ICA/CCA velocity ratio where appropriate
- Doppler waveform characteristics
- Flow direction
- Velocity acceleration through stenosis
How does carotid ultrasound relate to cardiovascular risk assessment?
Cardiovascular risk assessment begins with established clinical risk factors and validated risk models. Carotid imaging may add anatomical information in selected patients, particularly by demonstrating the presence or absence of carotid plaque.
Age, blood pressure, cholesterol, smoking, diabetes and other established factors.
In UK practice, cardiovascular risk assessment is commonly structured around NICE guidance and QRISK3 where appropriate.
Carotid plaque or coronary artery calcium may add information in selected people when risk is uncertain.
Results must be considered alongside history, symptoms, family history, blood tests and other investigations.
The practical implication is that the strongest value of a carotid cardiovascular assessment is not simply “What is my CIMT number?” A more complete question is whether there is evidence of focal atherosclerotic plaque, how extensive it is, and whether there is any associated haemodynamically significant stenosis.
What does carotid plaque mean?
Carotid plaque is structural evidence of atherosclerotic disease within the carotid arterial system. It does not necessarily mean that a carotid artery is severely blocked, and it does not mean that a future heart attack or stroke is inevitable.
For cardiovascular prevention, this distinction matters. A report may legitimately describe “carotid atherosclerotic plaque with no haemodynamically significant stenosis”. This indicates visible atherosclerotic disease without major flow-limiting narrowing.
When might carotid cardiovascular assessment be considered?
Established risk factors
- Hypertension
- Raised LDL cholesterol
- Diabetes
- Smoking history
- Obesity or metabolic syndrome
Family or clinical context
- Strong family history of premature cardiovascular disease
- Known atherosclerosis in another vascular territory
- Previous coronary artery disease
- Peripheral arterial disease
Selected prevention questions
- Uncertain overall cardiovascular risk
- Risk discussion near a treatment threshold
- Prior carotid plaque requiring follow-up for a defined clinical reason
What might a carotid report include?
| Report component | What it describes | Why it matters |
|---|---|---|
| CIMT measurements | Thickness of the intima-media complex in a defined carotid segment. | Provides information about arterial wall thickness but should not be interpreted as a stand-alone risk score. |
| Plaque presence | Whether focal atherosclerotic plaque is visualised. | Demonstrates structural carotid atherosclerosis. |
| Plaque location | For example, common carotid, bulb or proximal internal carotid artery. | Helps document distribution and plaque burden. |
| Plaque morphology | Echogenicity, heterogeneity, surface appearance and calcification where assessable. | Describes structural features but does not independently predict an individual event. |
| Doppler velocities | PSV, EDV and relevant velocity ratios. | Used with imaging findings to assess stenosis severity. |
| Conclusion | Overall summary of plaque, stenosis and blood-flow findings. | Guides whether clinical follow-up or further vascular assessment may be appropriate. |
What does “no haemodynamically significant stenosis” mean?
Carotid stenosis describes narrowing of the artery. A carotid duplex scan assesses the appearance of the arterial lumen and plaque together with Doppler blood-flow velocities.
Plaque without significant stenosis
Plaque can be present while the artery remains widely patent and Doppler velocities remain within a non-stenotic range. This is common in early or non-obstructive carotid atherosclerosis.
Flow-limiting stenosis
More substantial narrowing may accelerate flow through the affected segment and alter Doppler velocity parameters. Duplex criteria are used alongside visible plaque and luminal narrowing to grade stenosis.
How is carotid ultrasound different from a coronary calcium score?
| Test | Main information | Radiation? | Important limitation |
|---|---|---|---|
| CIMT | Carotid arterial wall thickness | No | Not recommended as a routine stand-alone risk-reclassification test |
| Carotid plaque ultrasound | Direct visualisation of focal carotid atherosclerosis | No | Does not directly visualise the coronary arteries |
| Carotid duplex | Carotid structure plus blood-flow haemodynamics | No | Primarily evaluates extracranial carotid circulation |
| Coronary artery calcium (CAC) | CT-based quantification of calcified coronary atherosclerosis | Yes, low-dose CT | Detects calcified coronary plaque rather than all plaque types |
The most appropriate investigation depends on the clinical question, the individual’s baseline risk and the information needed to guide management.
What happens during a CIMT and carotid duplex scan?
Preparation
No fasting is usually required. You can generally eat, drink and take usual medication normally. Clothing that allows easy access to the neck is helpful, and necklaces may need to be removed.
Radiation and discomfort
Carotid ultrasound uses sound waves and does not involve ionising radiation, injections or arterial catheters. The scan is usually painless, although gentle probe pressure is required.
What carotid ultrasound cannot tell you
It cannot directly assess
- Coronary artery narrowing
- Heart muscle function
- Cardiac rhythm disorders
- All intracranial arteries
- Every possible cause of stroke
- Whether or when a heart attack will occur
A normal scan does not mean zero cardiovascular risk
A person can have normal carotid findings and still have cardiovascular risk arising from coronary atherosclerosis, hypertension, diabetes, smoking, arrhythmia or other conditions.
Conversely, finding carotid plaque does not mean that a stroke or heart attack is inevitable.
When a routine carotid scan is not the right pathway
Similarly, new severe chest pain, severe breathlessness, collapse or symptoms concerning for an acute cardiac event require urgent medical assessment rather than cardiovascular screening.
What happens if plaque is found?
Finding carotid plaque does not automatically mean that a procedure or surgery is required. Many people have non-stenotic plaque that is managed by reviewing and treating cardiovascular risk factors.
Risk-factor review
Blood pressure, cholesterol, diabetes status, smoking, weight, kidney function and family history may need review.
Clinical interpretation
The result should be considered alongside QRISK3 or other clinically appropriate risk assessment rather than in isolation.
Further assessment
Depending on findings and overall risk, your clinician may consider additional cardiovascular or vascular investigation.
Treatment decisions — including lipid-lowering therapy, antihypertensive medication or antiplatelet treatment — should be made by an appropriately qualified prescribing clinician.
Should CIMT or carotid plaque be monitored every year?
Routine annual CIMT measurement is not automatically necessary. Small differences between examinations can result from measurement technique, image quality or the exact arterial segment selected rather than true biological change.
Repeat carotid imaging should therefore have a defined clinical purpose — for example, follow-up of known carotid disease where recommended — rather than simply repeating a CIMT number at arbitrary intervals.
A broader carotid assessment — not just one CIMT number
At UKSONO Healthcare
Where CIMT is included, it is interpreted as one component of a broader carotid assessment. A comprehensive carotid examination may consider arterial-wall thickness, focal plaque, plaque distribution, morphology, luminal narrowing and Doppler blood-flow findings.
The purpose is to provide clinically meaningful vascular information that can be interpreted alongside your wider cardiovascular risk profile.
CIMT & carotid duplex FAQs
Is CIMT the same as a carotid Doppler?
No. CIMT specifically measures arterial-wall thickness. A carotid duplex examination assesses arterial structure, plaque, narrowing and Doppler blood flow.
Can I have normal CIMT but still have carotid plaque?
Yes. CIMT and focal plaque are distinct findings. A plaque can occur at the carotid bulb or proximal internal carotid artery even when a separate common-carotid CIMT measurement is not markedly increased.
Can I have carotid plaque without significant narrowing?
Yes. Non-stenotic plaque is common. The report may identify atherosclerotic plaque while stating that there is no haemodynamically significant stenosis.
Does carotid plaque mean I have coronary artery disease?
Not necessarily. Carotid plaque is evidence of atherosclerosis in the carotid circulation and may indicate a higher likelihood of atherosclerosis elsewhere, but carotid ultrasound cannot directly diagnose coronary artery disease.
Can CIMT predict a heart attack?
Not by itself. CIMT is associated with cardiovascular risk at a population level, but it cannot determine whether or when an individual will have a heart attack.
Can a carotid ultrasound predict stroke?
It can identify carotid plaque and stenosis, which are relevant to stroke risk, but strokes have multiple causes. A normal carotid scan does not eliminate overall stroke risk.
Is CIMT routinely recommended for cardiovascular risk screening?
No. Routine CIMT measurement alone is not universally recommended for cardiovascular-risk assessment. Established clinical risk assessment remains the starting point.
Does the scan use radiation?
No. Ultrasound and Doppler use high-frequency sound waves and do not involve ionising radiation.
Do I need a GP referral?
Many UKSONO ultrasound services accept self-referral. Urgent neurological or cardiac symptoms should follow the appropriate urgent NHS pathway rather than routine screening.
Will I receive a written report?
Yes. A written diagnostic ultrasound report is provided according to the service pathway.
Book a private carotid duplex ultrasound
Assess carotid plaque, blood flow and carotid stenosis with a detailed bilateral carotid ultrasound. If CIMT assessment is required, confirm availability when booking.
References & further reading
- Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004–2006–2011). Cerebrovascular Diseases. 2012;34:290–296. PubMed: 23128470.
- Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim intima-media thickness consensus. Plaque definition includes focal encroachment ≥0.5 mm, ≥50% of the surrounding IMT, or thickness >1.5 mm. PubMed: 17108679.
- European Society of Cardiology. Cardiovascular prevention guidance and risk-modifier discussion: CIMT measurement is not recommended for routine risk reclassification; carotid plaque detection may be considered when coronary artery calcium scoring is unavailable or not feasible. ESC Cardiovascular Practice.
- NICE. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guideline NG238. NICE NG238.
- Johri AM, Nambi V, Naqvi TZ, et al. Recommendations for the assessment of carotid arterial plaque by ultrasound for characterization of atherosclerosis and evaluation of cardiovascular risk. Journal of the American Society of Echocardiography. 2020. PubMed: 32600741.
- Intersocietal Accreditation Commission (IAC). Updated Recommendations for Carotid Stenosis Interpretation Criteria. 2023. IAC Vascular Testing.
This article is for education and does not replace personalised medical advice. Cardiovascular risk assessment, medication decisions and treatment should be made with an appropriately qualified healthcare professional using the complete clinical picture. Guidance may change over time.